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Background: Adiponectin (APN) has insulin-sensitizing, anti-atherogenic and cardiomyocyte-protecting properties, and exhibits inverse 
associations with left ventricular (LV) mass, diastolic dysfunction, and cardiovascular disease (CVD) in healthy middle-aged cohorts. In older adults, 
higher APN levels are associated with LV dysfunction and CVD events, but the prospective association of APN with incident heart failure (HF) remains 
unexamined.
Methods: We investigated the relationships of total and high-molecular-weight (HMW) APN with incident HF in the Cardiovascular Health Study, 
a community-based longitudinal cohort of adults ages 65 and older. Total and HMW APN were measured by ELISA in 3,228 participants free 
of prevalent HF or CVD (age 74±5, 63.5% women).
Results: During median follow up of 12 years, 780 HF events occurred. Adjusted cubic splines revealed that the relationships of total and HMW 
APN with new-onset HF were nonlinear. Concentrations below their medians (12.4 and 6.2 mg/L, respectively) were not significantly associated with 
incident HF, whereas higher levels were positively associated with this outcome. After adjustment for age, sex, race, income, education, hypertension, 
smoking, alcohol, ACE inhibitors, eGFR, BMI and health status, the HRs per SD increment in total APN were 0.93 (95% CI 0.72-1.21) below the 
median and 1.25 (95% CI 1.14-1.38) above it. These relationships were not influenced by putative mediators (glycemic, lipid and inflammatory 
measures). There was significant effect modification by BMI (p=0.005), in which total APN levels above the median were significantly associated with 
HF in subjects with BMI<25 kg/m2 (HR 1.37 [95% CI 1.21-1.55]). Results were not altered by exclusion of subjects with elevated NTproBNP or prior 
unintentional weight loss, and were similar for HMW adiponectin. 
Conclusion: Total and HMW APN exhibited comparable relationships with incident HF in this older cohort. A threshold effect of increasing risk 
occurred at their median concentrations but was limited to individuals with BMI <25 kg/m2. Among leaner older adults, high levels of APN may mark 
or mediate age-related processes that lead to myocardial dysfunction and HF.
